CARLSON INV. ZY 13 Total Liabilities
CARLSON INV. ZY 13 total liabilities. Based on the latest financial reports, CARLSON INV. ZY 13 (2HB) has total liabilities worth €1.12 Million EUR (≈ $1.31 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 2HB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of CARLSON INV. ZY 13 (2021–2025)
Total liabilities of CARLSON INV. ZY 13 from 2021 to 2025. This chart illustrates how CARLSON INV. ZY 13's total liabilities have evolved over time, based on quarterly financial data.
CARLSON INV. ZY 13 Competitors by Total Liabilities
The table below lists competitors of CARLSON INV. ZY 13 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ARK Resources Bhd
KLSE:7007
|
Malaysia | RM41.45 Million |
|
Ignite Ltd
AU:IGN
|
Australia | AU$4.89 Million |
|
Traws Pharma Inc
NASDAQ:TRAW
|
USA | $9.78 Million |
|
Strategem Capital Corp
V:SGE
|
Canada | CA$54.00K |
|
UNITH LTD.
F:CM30
|
Germany | €1.61 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
USA | $7.14 Million |
|
Kane Biotech Inc
V:KNE
|
Canada | CA$3.48 Million |
|
Resources & Energy Group Ltd
AU:REZ
|
Australia | AU$1.61 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down CARLSON INV. ZY 13's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CARLSON INV. ZY 13 total assets.
Liquidity & Leverage Metrics
CARLSON INV. ZY 13 Total Liabilities Ratios Explained
CARLSON INV. ZY 13 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 24.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CARLSON INV. ZY 13's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CARLSON INV. ZY 13 (2021–2025)
The table below shows the annual total liabilities of CARLSON INV. ZY 13 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.12 Million ≈ $1.31 Million |
-75.08% |
| 2024-12-31 | €4.50 Million ≈ $5.26 Million |
-4.63% |
| 2023-12-31 | €4.72 Million ≈ $5.52 Million |
-32.53% |
| 2022-12-31 | €7.00 Million ≈ $8.18 Million |
+27.05% |
| 2021-12-31 | €5.51 Million ≈ $6.44 Million |
-- |
About CARLSON INV. ZY 13
Carlson Investments SE is a venture capital firm specializing in seed, early, growth capital and pre-IPO investments. The firm prefer to make investments in financial, medical, and deep technology industries. The firm seeks to make investments in Europe, North America and Asia, with a particular focus on Central and Eastern Europe. The company was formerly known as Hotblok S.A. and changed its na… Read more